CLPT
Price
$11.47
Change
+$0.32 (+2.87%)
Updated
Apr 11 closing price
Capitalization
183.44M
31 days until earnings call
XTNT
Price
$0.41
Change
+$0.03 (+7.89%)
Updated
Apr 11 closing price
Capitalization
152.31M
25 days until earnings call
Ad is loading...

CLPT vs XTNT

Header iconCLPT vs XTNT Comparison
Open Charts CLPT vs XTNTBanner chart's image
ClearPoint Neuro
Price$11.47
Change+$0.32 (+2.87%)
Volume$176.92K
Capitalization183.44M
Xtant Medical Holdings
Price$0.41
Change+$0.03 (+7.89%)
Volume$198.58K
Capitalization152.31M
CLPT vs XTNT Comparison Chart
Loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPT vs. XTNT commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPT is a Hold and XTNT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (CLPT: $11.47 vs. XTNT: $0.41)
Brand notoriety: CLPT and XTNT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPT: 70% vs. XTNT: 237%
Market capitalization -- CLPT: $183.44M vs. XTNT: $152.31M
CLPT [@Medical Specialties] is valued at $183.44M. XTNT’s [@Medical Specialties] market capitalization is $152.31M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPT’s FA Score shows that 0 FA rating(s) are green whileXTNT’s FA Score has 1 green FA rating(s).

  • CLPT’s FA Score: 0 green, 5 red.
  • XTNT’s FA Score: 1 green, 4 red.
According to our system of comparison, XTNT is a better buy in the long-term than CLPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPT’s TA Score shows that 5 TA indicator(s) are bullish while XTNT’s TA Score has 4 bullish TA indicator(s).

  • CLPT’s TA Score: 5 bullish, 3 bearish.
  • XTNT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLPT is a better buy in the short-term than XTNT.

Price Growth

CLPT (@Medical Specialties) experienced а +3.99% price change this week, while XTNT (@Medical Specialties) price change was -13.40% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.20%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was -3.81%.

Reported Earning Dates

CLPT is expected to report earnings on Aug 12, 2025.

XTNT is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-0.20% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPT($183M) has a higher market cap than XTNT($152M). XTNT YTD gains are higher at: -8.126 vs. CLPT (-25.423). XTNT has higher annual earnings (EBITDA): 5.59M vs. CLPT (-20.99M). CLPT has more cash in the bank: 23.1M vs. XTNT (8.66M). CLPT has less debt than XTNT: CLPT (13.9M) vs XTNT (23M). XTNT has higher revenues than CLPT: XTNT (78.5M) vs CLPT (24M).
CLPTXTNTCLPT / XTNT
Capitalization183M152M120%
EBITDA-20.99M5.59M-375%
Gain YTD-25.423-8.126313%
P/E RatioN/A51.50-
Revenue24M78.5M31%
Total Cash23.1M8.66M267%
Total Debt13.9M23M60%
FUNDAMENTALS RATINGS
CLPT vs XTNT: Fundamental Ratings
CLPT
XTNT
OUTLOOK RATING
1..100
6481
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
9594
PRICE GROWTH RATING
1..100
5386
P/E GROWTH RATING
1..100
10027
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPT's Valuation (51) in the null industry is in the same range as XTNT (78) in the Medical Specialties industry. This means that CLPT’s stock grew similarly to XTNT’s over the last 12 months.

CLPT's Profit vs Risk Rating (68) in the null industry is in the same range as XTNT (100) in the Medical Specialties industry. This means that CLPT’s stock grew similarly to XTNT’s over the last 12 months.

XTNT's SMR Rating (94) in the Medical Specialties industry is in the same range as CLPT (95) in the null industry. This means that XTNT’s stock grew similarly to CLPT’s over the last 12 months.

CLPT's Price Growth Rating (53) in the null industry is somewhat better than the same rating for XTNT (86) in the Medical Specialties industry. This means that CLPT’s stock grew somewhat faster than XTNT’s over the last 12 months.

XTNT's P/E Growth Rating (27) in the Medical Specialties industry is significantly better than the same rating for CLPT (100) in the null industry. This means that XTNT’s stock grew significantly faster than CLPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPTXTNT
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 24 days ago
81%
Bullish Trend 23 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLMEX15.46N/A
N/A
Harding Loevner Instl Emerg Mkts I
JDITX13.42N/A
N/A
JHancock Disciplined Value Intl R4
BMSVX12.48N/A
N/A
MFS Blended Research Mid Cap Eq R4
TEOOX7.82N/A
N/A
Transamerica Emerging Markets Eq R6
HLXCX9.90N/A
N/A
Harding Loevner Emer Mkt ex Chn Instl

CLPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPT has been loosely correlated with ICUI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPT jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPT
1D Price
Change %
CLPT100%
+2.87%
ICUI - CLPT
53%
Loosely correlated
+3.05%
ISRG - CLPT
42%
Loosely correlated
+0.83%
TNDM - CLPT
42%
Loosely correlated
+0.12%
ALGN - CLPT
42%
Loosely correlated
+2.50%
ILMN - CLPT
40%
Loosely correlated
+4.94%
More

XTNT and

Correlation & Price change

A.I.dvisor tells us that XTNT and STRRP have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XTNT and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTNT
1D Price
Change %
XTNT100%
+7.11%
STRRP - XTNT
31%
Poorly correlated
-0.24%
IQV - XTNT
25%
Poorly correlated
+1.63%
ICLR - XTNT
25%
Poorly correlated
+0.98%
MEHCQ - XTNT
25%
Poorly correlated
-1.71%
ACRS - XTNT
25%
Poorly correlated
+6.48%
More